Drug–drug interactions: is there an optimal way to study them?
Potential use of rapamycin in HIV infection
Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review
Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction
Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide
Comparison of the agonist-antagonist interaction model and the pool model for the effect of remoxipride on prolactin
Lack of clinically relevant drug–drug interactions when dalcetrapib is co-administered with ezetimibe
Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients
The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation
In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole
Repaglinide-gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanism
Evaluation of a QT nomogram for risk assessment after antidepressant overdose
Cortisol response to individualised graded insulin infusions: a reproducible biomarker for CNS compounds inhibiting HPA activation
(R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy
The NK1 receptor antagonist aprepitant does not alter the pharmacokinetics of high-dose melphalan chemotherapy in patients with multiple myeloma
Erlotinib and pantoprazole: a relevant interaction or not?
A response to: ‘A manifesto for clinical pharmacology from principles to practice’ by Jeff Aronson
Temporomandibular dislocation due to aripiprazole induced dystonia
Case discussion of an immediate serious reaction to hexavalent vaccine mistaken for anaphylaxis
Support by pharmacists for the therapy adherence of diabetes medication: a feasibility study
Drug related problems among elderly patients using five or more chronic drugs who are discharged from the hospital
Prospective evaluation of the tolerance to excipients in (pre)term neonates: the effects of propylene glycol exposure on renal and hepatic function
Additional safety risk to exceptionally approved drugs in EU?
Trastuzumab related cardiotoxicity in patients with primary or metastatic breast cancer: risk factors, reversibility and treatment
Population pharmacokinetics of lidocaine for seizure control in preterm and term neonates
Effect of gastric surgery and radiotherapy on the exposure to oral capecitabine in patients with gastric cancer
Why do patients experience adverse drug events? A prospective cohort study of 603 hospitalised patients?
Propofol-remifentanil anaesthesia in morbidly obese patients: developing rational dosing strategies
Sorafenib induced thyroiditis in patients with hepatocellular carcinoma
The pharmacokinetics of single dose asenapine during steady-state conditions of cyp450 and UGT modulators
Ciprofloxacin pharmacokinetics of different age categories in hospitalized patients
The influence of developmental changes on the pharmacokinetics of midazolam and metabolites in children
Capecitabine induced toxicity: an outcome study into drug safety
Influence of CYP2D6 phenotype on tamoxifentreatment outcome in women with metastatic breast cancer
Switching to generic anti-epileptic medicines: a regulatory perspective
Hyponatremia in elderly patients treated with antidepressant drugs: a cross-sectional study on prevalence and clinical characteristics
Mediciation review projects in The Netherlands
The effect of a clinical adherence trial on adherence to non-study medication
Concordance with recommended guidelines for the drug treatment of severe anaphylaxis in an emergency department
Retrospective analysis of 8 years of efavirenz drug monotoring data
Investigation of the effect of ketoconazole on the pharmacokinetics of macitentan in healthy male subjects
Perineal block with prilocaine during labour: effect on the newborn - A pilot study
Translation Section